Keywords: japan, generic, drugs, market, expected, grow, japanese
Japan's generic drugs market expected to grow 8.8% from 2006 to 2008
Article | 27 November 2006
The Japanese market for generic drugs will see an 8.8% increase from an estimated 230.5 billion yen ($1.96 billion) in 2006 to 250.8 billion yen ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
